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uncoupling protein.weeks. Peroxisomal and mitochondrial structural features
were characterized using immunofluorescence and electron
microscopy. Mitochondrial function was assessed using high-
resolution respirometry. A novel targeted quantitative
proteomics method was applied to analyze 47 mitochondrial
proteins involved in oxidative phosphorylation, tricarboxylic acid
cycle and fatty acid b-oxidation pathways.
Results: Low protein diet-fed rats developed hypoalbuminemia
and hepatic steatosis, consistent with the human phenotype.
Hepatic peroxisome content was decreased and metabolomic
analysis indicated peroxisomal dysfunction. This was followed
by changes in mitochondrial ultrastructure and increased
mitochondrial content. Mitochondrial function was impaired
due to multiple defects affecting respiratory chain complex I
and IV, pyruvate uptake and several b-oxidation enzymes, leading
to strongly reduced hepatic ATP levels. Fenofibrate supplementa-
tion restored hepatic peroxisome abundance and increased mito-
chondrial b-oxidation capacity, resulting in reduced steatosis and
normalization of ATP and plasma albumin levels.
Conclusions:Malnutrition leads to severe impairments in hep-
atic peroxisomal and mitochondrial function, and hepatic meta-
bolic dysfunction. We discuss the potential future implications
of our findings for the clinical management of malnourished
children.
Lay summary: Severe malnutrition in children is associated with
metabolic disturbances that are poorly understood. In order to
study this further, we developed a malnutrition animal model
and found that severe malnutrition leads to an impaired function16 vol. 65 j 1198–1208
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of liver mitochondria which are essential for energy production
and a loss of peroxisomes, which are important for normal liver
metabolic function.
 2016 European Association for the Study of the Liver. Published
by Elsevier B.V. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Malnutrition still contributes to 45% of all global childhood
deaths below the age of 5 years [1]. Despite great achievements
in improved management of severely malnourished children,
for example through development of a World Health Organiza-
tion Guideline in 1999 [2], the condition remains difficult to treat
and in hospital fatality rates can be more than 30% [3,4]. In fact, it
is estimated that more than a half of a million children die each
year from severe malnutrition [1].
Severe malnutrition is defined by wasting but can also present
with more complex phenotypical characteristics, including
edema, hair discoloration, and hepatomegaly. Although a defi-
ciency of dietary protein and calories underlie the development
of severe malnutrition [5], the metabolic disturbances at the cel-
lular level remain an enigma. Children hospitalized for severe
malnutrition are initially presented with profound electrolyte
disturbances, increased oxidative stress, hepatic steatosis and
decreased albumin synthesis (hypoalbuminemia) [6,7]. In addi-
tion, a recent study found an altered gut microbiome in children
with severe malnutrition, further underscoring the complexity of
this disease state [8].
Peroxisomes and mitochondria play key roles in various hep-
atic metabolic functions including lipid metabolism and energy
production, and dysfunction in these organelles are linked to
various disorders affecting liver, e.g., Zellweger syndrome and
non-alcoholic fatty liver disease [9]. Peroxisomes are single
membrane bound organelles that are important for bile acid
synthesis, b-oxidation of very long-chain fatty acids (VLCFA)
and cellular redox homeostasis [10], as well as the maintenance
of normal mitochondrial function [11]. In turn, mitochondria are
essential for aerobic ATP production, fatty acid b-oxidation
(FAO) (acyl-chain length of 6C20), ketogenesis and gluconeoge-
nesis from pyruvate and tricarboxylic acid (TCA) cycle interme-
diates. Defect in these two organelles have been shown to cause
various degrees of liver dysfunction resulting in clinical pheno-
types similar to those observed in severely malnourished indi-
viduals, e.g., increased oxidative stress and hepatic steatosis
[12,13]. Furthermore, we recently provided some evidence for
a relative decrease in hepatic mitochondrial function in severely
malnourished children with signs of metabolic maladaptation
[14].
To study the physiological and cellular changes that drive
hepatic pathogenesis in malnutrition we placed weanling rats
on a low protein diet (LPD) for four weeks. Using this animal
model, we showed that a LPD led to early loss of hepatic peroxi-
somes followed by mitochondrial dysfunction with severe meta-
bolic disturbances and energy depletion. Induction of
peroxisomal biogenesis and boosting of mitochondrial FAO by
fenofibrate treatment resulted in a profound amelioration of
the metabolic phenotype, including normalization of serum albu-
min levels and restored hepatic energy status.Journal of Hepatology 2016Materials and methods
Animals
Pregnant Wistar rats (Harlan Laboratories, Venray, The Netherlands) were housed
in a temperature-controlled environment (21 C) and 12 h, 12 h light:dark cycle
with ad libitum access to regular chow and water. The offspring were kept with
the mother until day 21 when male animals were placed on either a LPD (5% of
calories from protein) or control diet (20% of calories from protein, as described
in Supplementary Table 1) (Harlan, Madison, WI, USA). Animals were kept on
the diet for 1 or 4 weeks as indicated. In a different set of experiments, the off-
spring were weaned to a 5% protein and after 2 weeks, half of the rats received
the 5% protein diet supplemented with 0.1% (wt/wt) fenofibrate for another
2 weeks. The animal treatment conformed to the guidelines of The Institutional
Animal Care and Use Committee of the University of Groningen and was in accor-
dance with EC Directive 86/609/EEC for animal experiments.
Biochemical analyses
Plasma and hepatic metabolite analysis, enzyme activity assays and Western blot
analysis were carried out as detailed in the Supplementary materials.
Histology and microscopy
Livers were immediately fixed after harvesting as detailed in the Supplementary
materials followed by histological and ultrastructural analyses.
Isolation of liver mitochondria and high-resolution respirometry
Liver mitochondria were isolated by differential centrifugation and oxygen con-
sumption rates were measured at 37 C using a two-channel high-resolution Oro-
boros oxygraph-2 k (Oroboros, Innsbruck, Austria) as described in detail in
Supplementary materials.
Targeted quantitative mitochondrial proteomics
Selected 47 mitochondrial proteins involved in substrate transport, FAO and TCA
cycle were quantified in isolated mitochondria using isotopically labeled stan-
dards (13C-labeled lysines and arginines), derived from synthetic protein concate-
mers (QconCAT) (PolyQuant GmbH, Bad Abbach, Germany) as described in
Supplementary materials.
Transcriptomics
RNA expression profiling was performed using Affymetrix Gene chip Rat Gene 1.1
ST arrays according to standard Affymetrix protocols and data were deposited to
Gene Expression Omnibus (NCBI, accession number GSE63096).
Statistical analysis
All values are reported as means ± S.D. Depending on the type of experiment, Stu-
dent’s t test or ANOVA was used for statistical evaluation of data as described in
detail in Supplementary materials. All analyses were performed with IBM SPSS
Statistics 22.0 (SPSS Inc., Chicago, IL, USA). Differences were considered signifi-
cant at p <0.05.Results
LPD leads to severe growth retardation and hepatic steatosis
We first aimed to determine the general phenotypic effects of a
LPD diet. Fig. 1 shows basic animal characteristics after 4 weeks
of LPD or control diet (5% and 20% of calories from protein,
respectively). We aimed to keep the total caloric density and
fat content equal between the diets. The LPD-fed rats had avol. 65 j 1198–1208 1199
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Fig. 1. Severe growth failure and hepatic steatosis in LPD-fed rats. (A) Growth curves. (B) Food intake. (C) Plasma triglyceride, albumin, alanine-transaminase, lactate,
b-hydroxybutyrate and fasting glucose concentrations. (D) Liver weights, body weight-normalized liver weights, hepatic triglycerides, glycogen and thiobarbituric acid
reactive substances (TBARS). Data are means from N = 6 animals per diet group; ± SD. ⁄p <0.05, ⁄⁄p <0.001 compared to 20% protein diet group.
Research Articlestunted phenotype exemplified by a lower body weight and body
length. Albeit in absolute terms LPD-fed animals consumed less
chow, they consumed more chow per unit body weight over time
(Fig. 1A and B). However, body weight-normalized protein intake
was still nearly two-fold lower at the end of the experiment, indi-
cating that impaired growth was specifically due to lower protein
intake.
As expected, plasma concentrations of essential amino acids
(except histidine) were significantly lower in the LPD-fed animals
(Supplementary Table 3). Rao et al., also noted an increase in his-
tidine in an animal model of malnutrition and other work has
also shown that histidine levels are not decreased during severe
malnutrition in children [15]. The etiology is unclear, but staple
foods like corn contain significant amounts of histidine and might
play a role in the clinical observations. The concentrations of
most non-essential amino acids were not affected or and in some
cases even increased (serine) compared to the controls (Supple-
mentary Table 3), suggesting metabolic compensation. The limi-
tation of amino acids is expected to reduce protein synthesis
thereby sparing amino acids that are relatively abundant in the
diet. Plasma triglyceride (TG) and albumin concentrations were
decreased, while alanine-aminotransferase (ALT) levels were ele-
vated in LPD-fed animals (Fig. 1C). Lactate concentrations were
comparable in both groups under fed and fasted conditions, while
b-hydroxybutyrate concentrations were similar under fed condi-
tions, but were higher in LPD group under fasting conditions
(Fig. 1C), with similar insulin concentrations (data not shown),
possibly indicating a reduction in TCA cycle activity. Fasting glu-
cose levels were lower in LPD-fed animals suggesting impaired
hepatic glucose production (Fig. 1C).
The absolute liver weights were lower in LPD-fed group, while
body weight-normalized liver weights were comparable (Fig. 1D).
The livers of LPD-fed animals were pale in color (Supplementary
Fig. 1A), presumably due to increased TG content, which was1200 Journal of Hepatology 2016indeed higher compared to the controls already after one week
of LPD and in line with haematoxylin and eosin staining, showing
steatosis (Fig. 1D; Supplementary Fig 1B). The steatosis was
mainly located periportally (zone 1) and in zone 2, while the
perivenous area (zone 3) was not affected. Ultrastructural
electron microscopy (EM) analyses corroborated these findings
(Supplementary Fig. 2). Glycogen content was similar between
groups (Fig. 1D; Supplementary Fig. 1C). The content of thiobarbi-
turic acid reactive substances (TBARS) was increased in livers of
LPD-fed animals, suggesting increased oxidative stress (Fig. 1D).
LPD leads to diminished hepatic peroxisome content and impaired
peroxisomal function
A possible cause of hepatic steatosis is the loss or dysfunction of
the organelles involved in lipid catabolism. In mammalian cells,
FAO occurs in both mitochondria and peroxisomes. EM revealed
a near absence of peroxisomes in the periportal area of livers of
LPD-fed animals compared to controls (Fig. 2A and C). Decreased
immunofluorescence staining of peroxisomal membrane protein
PEX14 confirmed the loss of peroxisomes specifically in the peri-
portal area (Fig. 2B and D). Furthermore, protein levels of perox-
isomal membrane protein 70 (PMP70) and matrix protein
catalase were decreased after 4 weeks of LPD (Fig. 3A and B).
The observation of lower hepatic PMP70 protein levels already
after 1 week of LPD (Fig. 3A) suggested that the loss of hepatic
peroxisomes occurs at the early stages of protein malnutrition.
The loss of peroxisomes in the periportal region can be either
due to a decrease in biogenesis or an increase in turnover. Perox-
isomes are degraded by selective autophagy (pexophagy), which
can be induced by amino acid deprivation [16]. This process
requires concerted effort of autophagy receptors, p62/SQSTM1
and NBR1, which specifically bind and target peroxisomes for
degradation [17]. However, accumulation of p62 is commonlyvol. 65 j 1198–1208
Fig. 2. LPD induces changes in hepatic peroxisomal distribution (A) Electron
micrograph of periportal hepatocyte from a control animal, showing a peroxi-
some (arrow) and numerous mitochondria. (B) Immunofluorescent staining of
peroxisome marker PEX14 (red) of liver periportal area from a control animal,
with nuclei in blue. (C) Electron micrograph of periportal hepatocyte from LPD-
fed animal. Note the absence of peroxisomes, presence of electron opaque lipid
and numerous abnormal mitochondria. (D) Pex14 staining of periportal area of
liver in LPD-fed animal, showing decreased signal. (E) Periportal area of liver from
a fenofibrate-treated animal. Mitochondria morphology has improved and
peroxisomes have reappeared (arrows). (F) Pex14-stained perivenous area of
liver in LPD-fed animal.
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Fig. 3. LPD causes loss of peroxisomal proteins and increases levels of
biochemical markers indicating peroxisomal dysfunction. (A) Protein levels of
Pmp70 in livers. (B) Protein levels of catalase in livers. (C) Hepatic content of
hexacosanoic acid (C26:0) and the ratios of C24/C22, C25/C22 and C26/C22 in
livers. (D) Hepatic polyunsaturated fatty acid profile. (E) Plasma bile acid and bile
acid intermediate profiles. Data are means from N = 6–8 animals per experimen-
tal group; ± SD. ⁄p <0.05 and ⁄⁄p <0.001 compared to 20% protein diet group.
JOURNAL OF HEPATOLOGYseen in defective autophagy. Protein levels of autophagy marker
LC3-II were elevated in liver after both 1 and 4 weeks of LPD, sug-
gesting stimulation of autophagy. Levels of p62 were reduced
after 1 week and elevated after 4 weeks in our LPD animals, the
latter also being the case for NBR1 (Supplementary Fig. 3A–G).
The combined data suggests that autophagy is activated in our
malnutrition model and that the loss of peroxisomes could be
related to degradation. However, our data potentially indicates
a block in autophagic flux after prolonged malnutrition.
Prolonged starvation has also been shown to cause an elevation
of p62 and NBR1 levels, which may contribute to the elevated
levels observed after 4 weeks LPD [18]. Although we cannot rule
out a role for impaired peroxisome biogenesis to explain the loss
of peroxisomes in our LPD model, we did not observe changes inJournal of Hepatology 2016expression of genes involved in peroxisome biogenesis (see
below).
Since b-oxidation of VLCFA takes place in peroxisomes, we
analyzed hepatic VLCFA composition. Hepatic content of hexa-
cosanoic (C26) (Fig. 3C) and docosatetraenoic acid (C22:4x6)
(Fig. 3D) as well as C26/C22 ratios (Fig. 3C) were increased in liv-
ers of LPD-fed animals, while the content of docosahexaenoicvol. 65 j 1198–1208 1201
Fig. 4. LPD induces formation of deformed and elongated mitochondria.
Fluorescent immunohistochemistry of mitochondrial Hsp60 (red) in liver sections
in (A, B) periportal and (C, D) perivenous area. Panels below are zoomed sections
of the area indicated in the corresponding panels above. Size bar equals 10 lm.
Research Article
acid (C22:6x3) was decreased (Fig. 3D). Similar changes in C26
and C22:6x3 levels were reported in patients with Zellweger’s
syndrome [19], that lack functional peroxisomes. In agreement
with patient data, plasma levels of di- and trihydroxycholestanoic
acid (DHCA and THCA, respectively), bile acid intermediates that
are metabolized by peroxisomal b-oxidation, were elevated in
LPD-fed animals. Increased plasma concentrations of unconju-
gated bile acids also pointed to a peroxisomal defect (Fig. 3E),
as bile acid conjugation is a peroxisomal process [20].
Accumulation of deformed hepatic mitochondria in response to LPD
Further EM analysis revealed increased numbers of deformed
mitochondria in livers of LPD-fed animals (Fig. 2C; Supplemen-
tary Fig. 4). Mitochondria (in particular in zone 1) appeared
enlarged with abnormal cristae, formed loops, contained inclu-
sion bodies and increased numbers of mitochondrial granules.
Immunofluorescence imaging of mitochondria substantiated the
finding of enlarged and looped organelles in all hepatic zones of
LPD-fed animals (Fig. 4), a phenomenon that has also been
observed in cultured cells grown under amino acid deprivation
conditions [21]. Furthermore, mitochondria elongation factor
mitofusin-2 (Mfn2) was increased in isolated mitochondria from
LPD-fed group (Supplementary Fig. 3H). In addition, staining
appeared more intense in the LPD-fed group suggesting an
increased mitochondrial volume-density. This was confirmed by
elevated relative mitochondrial (mt)DNA copy number and
increased content of mitochondrial marker protein TOM20.
However, in contrast to the early loss of peroxisomal markers,
mitochondrial parameters were not yet altered after 1 week of
LPD (Fig. 5A and B).
Hepatic mitochondrial function is severely impaired in LPD-fed rats
Next we determined whether changes in mitochondrial ultra-
structure affected mitochondrial respiratory function. The basal
oxygen consumption rates were not affected by the diet
(Fig. 5C). In contrast, ADP-stimulated oxygen consumption rates
(state 3) were lower in mitochondria from LPD-fed group
(Fig. 5C). The strongest decrease was observed with pyruvate plus
malate (PM), followed by palmitoyl-CoA plus L-carnitine plus
malate (PCM) and succinate plus pyruvate plus malate (SPM).
This indicates impaired oxidative phosphorylation (OXPHOS)
complex I activity, since dependence of oxygen flux on complex
I activity is decreasing in the order PM>PCM>SPM. A milder
impairment of oxygen consumption in the uncoupled state
(Fig. 5C), in which ATP synthesis is inactivated due to dissipation
of proton gradient, suggested both respiratory chain and ATP syn-
thesis defects. Hepatic ATP content was indeed 40% reduced and
AMP content was elevated (Fig. 6D), leading to strongly increased
AMP/ATP ratio (Fig. 6D) and increased phosphorylation levels of
AMP-activated protein kinase a subunit (AMPKa) (Fig. 5B). This
implies that impaired mitochondrial ATP production was not
compensated by increased mitochondrial mass.Molecular underpinnings of LPD-induced mitochondrial dysfunction
To establish the molecular basis for LPD-induced mitochondrial
dysfunction we determined protein levels and activities of
enzymes involved in mitochondrial energy metabolism. There
was a strong reduction in both OXPHOS complex I activity and1202 Journal of Hepatology 2016level of Ndufb8 (Fig. 5D), which is needed for assembly and sta-
bility of complex I [22]. Complex IV activity and protein levels
of subunit 1 were decreased as well in the LPD group (Fig. 5D).
Proteomics analysis confirmed the strong effect of LPD on com-
plex I and IV (Ndufs1 and Cox5a, respectively, Supplementary
Fig. 5B and C).
The observation that pyruvate-driven oxygen consumption
rates were affected more than those driven by fatty acid (FA) sub-
strate suggested that OXPHOS capacity is not the only factor that
limited pyruvate oxidation. Proteomics showed that pyruvatevol. 65 j 1198–1208
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N = 5–6, except for adenosine (mono-/di-/tri-)phosphates; N = 3; ± SD. ⁄⁄p <0.001 and ⁄p <0.05 compared to 20% protein diet group after 4 weeks of diet. ++p <0.001 and
^^p <0.001 compared to 20% and 5% protein diet group after 1 week of diet, respectively.
JOURNAL OF HEPATOLOGYdehydrogenase complex enzymes (Pdha1, Dlat and Dld) were not
influenced by LPD (Supplementary Fig. 5A). However, microarray
data analysis revealed downregulation of mitochondrial pyruvate
carrier subunit 1 (Mpc1 1.47 fold, p = 0.016), suggesting that
pyruvate uptake, which has been shown to be rate limiting for
pyruvate oxidation [23], was decreased under LPD conditions.
Protein levels of other mitochondrial substrate transporters were
also decreased (Supplementary Fig. 5A), suggesting decreased
supply of substrates for TCA cycle. This was accompanied by
lower hepatic content of TCA cycle intermediates fumarate,
malate and a-ketoglutarate, yet TCA cycle enzymes levels were
not affected (Fig. 5E; Supplementary Fig 5A).
The proteomic analysis of mitochondrial FAO enzymes
showed that LPD had no effect on the carnitine palmitoyltrans-Journal of Hepatology 2016ferase (Cpt) system that catalyzes acyl-CoA uptake into mito-
chondrial matrix (Supplementary Fig. 5E), while three FAO
enzymes, i.e., medium-chain specific acyl-CoA dehydrogenase
(Acadm), medium and short-chain L-3-hydroxyacyl-coenzyme A
dehydrogenase (Hadh) and enoyl-CoA hydratase (Echs1), were
decreased (Fig. 6E). In line with lower mitochondrial FAO capac-
ity and the absence of peroxisomes, LPD caused accumulation of
long-chain acyl-carnitines (C14-C18) (Fig. 5E). Moreover, the con-
tent of acetylcarnitine (C2) increased in the LPD group (Fig. 5E),
suggesting decreased utilization of acetyl-CoA in the TCA cycle
leading to an increase in ketogenesis despite impaired FAO
(Fig. 1C).
Steatosis and mitochondrial dysfunction has been linked to
endoplasmic reticulum (ER) stress. Therefore markers of the 3vol. 65 j 1198–1208 1203
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Research Articlebranches of the unfolded protein response (UPR) that is activated
by ER stress [24] were analyzed next. In accordance with the
transcriptomic data however, levels of both the transcription fac-
tors XBP1 s and spliced ATF6 that initiate the 2 specific branches
of the UPR remained similar to control animals, as well as their
targets ERP72 and GRP78 (Supplementary Fig. 5F and G).
Increased eIF2a phosphorylation and CCAAT-enhancer-binding
protein homologous (CHOP) protein could be clearly observed
though, strongly suggesting another form of stress. This is in line
with data indicating that amino acid deprivation through GCN2 is
activating the third branch also known as the integrated stress
response [24].
Microarray reveals transcriptional upregulation of major
mitochondrial pathways without changes in peroxisomal gene
expression
To gain further insight in the etiology of LPD-induced peroxiso-
mal and mitochondrial alterations as well as the development
of steatosis, liver transcriptome profiling was performed.1204 Journal of Hepatology 2016Microarray data analysis revealed that 24% of the genes (4707
genes, FDR <5%) expressed in liver were differentially expressed
after 4 weeks of LPD. Transcription factor network analysis
showed enrichment of stress-induced transcription factor net-
works, including ATF3-5, HSF1 and CHOP, in line with our ER
stress protein data (Supplementary Table 4). Two targets of
ATF4 were particularly upregulated, Tribbles3, a pseudokinase
implicated in disrupting hepatic signaling pathways (33.6 fold),
and fibroblast growth factor 21 (FGF21; up 13.5 fold), which is
a central metabolic regulator induced by fasting [25].
The transcriptome analysis also revealed a lack of differential
regulation of lipogenic transcription factor networks, including
liver X receptor, sterol regulatory element-binding protein, or
peroxisome proliferator-activated receptor c (PPARc), suggesting
lipogenesis is not causing the steatosis, in line with the observed
AMPK activation that regulates lipogenesis post-
transcriptionally. Furthermore, there was no apparent
downregulation of genes coding for peroxisomal FA oxidation,
PMP70, or catalase in livers from LPD-fed animals. The expression
of peroxisomal biogenesis genes was also not consistentlyvol. 65 j 1198–1208
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changed, making it a less likely cause for reduced levels of perox-
isomal proteins (Supplementary Table 5).
Analysis of mitochondrial pathways revealed mitochondrial
amino acid metabolism, TCA cycle, OXPHOS and b-oxidation
among the pathways affected by LPD, while mitochondrial orga-
nization emerged as the strongest enriched biological function
(Fig. 5F) [26]. In line with increased mitochondrial content, the
gene-set enrichment analysis suggested transcriptional upregula-
tion of mitochondrial biogenesis in livers of LPD-fed animals as
indicated by the enrichment of mitochondrial gene expression
pathway (p <0.004), which includes key regulator of mitochon-
drial biogenesis peroxisome proliferator-activated receptor
gamma, coactivator 1 alpha (Ppargc1a, up 2.95 fold, p = 0.0003).
Upregulation of mitochondrial proteases and chaperones indi-
cated induction of quality control pathways (Supplementary
Table 6) and the presence of mitochondrial stress. Upregulation
of mitofusin 1 (Mfn1) and downregulation of mitochondrial fis-
sion protein 1 (Fis1) (Supplementary Table 6) was in agreement
with the observation of elongated mitochondria. Together these
data suggest that the observed mitochondrial functional impair-
ments are in part mediated transcriptionally.Fenofibrate reduces liver steatosis with restoration of peroxisomes,
mitochondrial FAO, ATP content and albumin synthesis
To better understand the role of peroxisome and mitochondrial
function on hepatic lipid metabolism we investigated whether
activating peroxisome proliferator-activated receptor alpha
(PPARa), a nuclear receptor that stimulates peroxisome biogene-
sis and mitochondrial nutrient oxidation [27], may improve hep-
atic metabolic function. We aimed to test the PPARa activator
fenofibrate after a period of exposure to a malnutrition-
inducing diet and development of steatosis. Treatment with
fenofibrate for 2 weeks, while maintaining the animals on LPD,
had no effect on the body weight, but it strongly reduced hepatic
TG content and restored plasma albumin concentrations (Fig. 6A),
suggesting improved liver function. Histology confirmed a
reduction in hepatic steatosis (Fig. 6B). EM showed increased
peroxisome numbers in the hepatic periportal regions of
fenofibrate-treated animals (Fig. 2E), that was confirmed by
increased hepatic PMP70 protein levels (Fig. 6C). Although,
PPARa activation has been shown to transcriptionally activate
autophagy, we observed a decrease in LC3II with fenofibrate
treatment. We therefore cannot rule out that, apart from
increased biogenesis, the increase in peroxisome numbers is
related to a downregulation of pexophagy.
Fenofibrate treatment had no effect on the mitochondrial den-
sity markers, i.e., hepatic TOM20 protein level and mtDNA copy
number remained higher compared to 20% protein diet-fed con-
trols (Fig. 6C and D). However, the treatment did improve mito-
chondrial morphology. Elongation was still commonly seen, but
the occurrence of large deformed mitochondria with inclusions
was decreased in response to fenofibrate treatment (Fig. 2E).
Importantly, hepatic ATP content was restored with a concomi-
tant reduction in the AMP/ATP ratio (Fig. 6E) and decreased phos-
phorylation levels of AMPKa (Fig. 6D), implying normalization of
mitochondrial ATP production. Analysis of FAO intermediates
revealed that fenofibrate treatment caused a nearly four-fold
increase in the hepatic free carnitine content (C0) (Fig. 6E), which
is required for mitochondrial acyl-CoA uptake. This is in agree-
ment with previous reports showing both stimulation of hepaticJournal of Hepatology 2016carnitine biosynthesis and enhanced hepatic carnitine uptake in
response to PPARa activation [28]. The content of long-chain
acylcarnitines (C14-C18) (Fig 6E), in particular C18 species
(Supplementary Fig. 6F), was strongly increased after fenofibrate
treatment. This suggested that the supply exceeded mitochon-
drial FAO capacity, which was also strongly increased as indi-
cated by nearly 45% higher oxygen consumption rate in the
coupled (Fig. 6F) and uncoupled states (Supplementary Fig. 6B)
and slightly higher basal oxygen consumption rate (Supplemen-
tary Fig. 6A) with FA substrate palmitoyl-CoA. Pyruvate-driven
oxygen consumption rates were minimally affected by fenofi-
brate treatment (Fig. 6F; Supplementary Fig. 6A and B), as well
as OXPHOS complexes, including complex I (Ndufb8 and Ndufs1)
and complex IV (Cox5A; Supplementary Figs. 5C, 6D and E).
Moreover, complex I activity was not restored by the activation
of PPARa (Supplementary Fig. 6C).
The differential effect of fenofibrate on the FA vs. pyruvate
oxidation in combination with the lack of effect on OXPHOS indi-
cates that the restoration of FAO by fenofibrate occurs upstream
of OXPHOS, i.e., of enzymes and transporters that are not
involved in pyruvate oxidation. Indeed, proteomics (Fig. 6G;
Supplementary Fig. 5E) showed massive upregulation of mito-
chondrial FAO enzymes, including Cpt1a, which controls b-
oxidation flux [29], and Acadm and Hadh both of which were
decreased in response to LPD.Discussion
Severe malnutrition is associated with a high risk of mortality
related to severe metabolic disturbances. But, despite its wide-
spread prevalence, in depth understanding of the pathophysio-
logical processes is lacking. In this study we present an in
depth examination of the hepatic cellular and metabolic pathol-
ogy in an animal model of severe malnutrition. We show that a
LPD in weanling animals causes severe periportal hepatic steato-
sis along with the loss of peroxisomes and impaired mitochon-
drial function. Mitochondria showed multiple functional defects
including a decrease in complex I and complex IV activity, and
impaired mitochondrial pyruvate and FA oxidation, resulting in
a profound hepatic energy deficit, despite an increase in mito-
chondrial abundance (see model, Fig. 7). Strikingly, activation of
nuclear receptor PPARa restored hepatic peroxisomal content
and increased mitochondrial FAO capacity but it did not rescue
either respiratory chain defects or pyruvate oxidation capacity.
The PPARa induction of peroxisomal biogenesis and stimulation
of mitochondrial FAO was sufficient to ameliorate hepatic steato-
sis and remarkably restore hepatic energy status and albumin
synthesis suggesting a link between the peroxisomal and mito-
chondrial dysfunction, and liver health during malnutrition. Our
study expands the understanding of early observations that sug-
gested impairment of mitochondrial bioenergetic functions in liv-
ers of severely malnourished rats [30,31] and humans [32] and
postulated a link between the loss of peroxisomal function and
development of a fatty liver in severe malnutrition [33].
Translating the animal model to the clinical phenotype of
malnutrition
Two clinical phenotypes of severe malnutrition exist. Marasmus
is defined by clinical wasting, while kwashiorkor is typicallyvol. 65 j 1198–1208 1205
Malnutrition
Fatty acid oxidation ↓
TCA cycle ↓
Oxidative phosphorylation ↓
Fatty acid oxidation ↓
Bile acid metabolism ↓
Hepatic steatosis
ATP deficit
Peroxisomes ↓
Mitochondria
Fig. 7. Model of LPD-induced loss of hepatic peroxisomes and mitochondrial
dysfunction. Loss of peroxisomes leads to altered bile acid synthesis and
metabolism and impaired oxidation of very long-chain fatty acids, whereas
mitochondrial dysfunction is characterized by impaired oxidative phosphoryla-
tion, TCA cycle and b-oxidation. Together these defects cause hepatic steatosis
and ATP deficit.
Research Articleaccompanied by more complex characteristics such as pitting
edema, hair discoloration, skin lesions and hepatomegaly,
although considerable overlap with marasmus often exists.
Biochemical features typically present in kwashiorkor include
hepatic steatosis [34,35], a reduced protein turnover [36] and
decreased albumin synthesis [37]. The plasma concentrations of
antioxidants are generally lower, while the levels of oxidative
stress markers are elevated [7,38]. Our malnutrition animal
model displayed both signs of marasmus and hallmarks of
kwashiorkor (hypoalbuminemia and hepatic steatosis). However,
the model lacked other specific clinical features of kwashiorkor
such as edema and skin lesions. It is possible that the dietary pro-
tein levels used in our model were too high to observe these phe-
notypes as a lower protein concentration in the diet was reported
to generate both edema and skin lesions [39]. However, dietary
protein deficiency is probably not the only factor needed to elicit
features of kwashiorkor as similar nutritional intake in terms of
quantity and composition has been observed in children with
kwashiorkor and marasmus [40]. Our animal model consisted
of feeding a LPD, replacing the protein with additional complex
carbohydrates, while maintaining the same 35% of sucrose by
chow weight for both the low protein and control diet. We aimed
to mimic what is generally observed in the developing countries
where staple food such as maize or cassava is generally low in
protein and high in carbohydrates. The diet also often has a sub-
stantial amount of refined sugar. Interestingly one of the first
hypotheses generated to explain the pathophysiology of kwash-
iorkor implicated carbohydrates to be involved in the pathogen-
esis and it is tempting to speculate that the combination of a diet
deficient in protein but high in carbohydrates also contributed to
the hepatic phenotype seen in our model [41]. Previous studies,
including in a non-primate monkey model [42], also suggested1206 Journal of Hepatology 2016that the combination of low protein and high carbohydrates
was able to induce the specific pathophysiological phenotype.
Comparing malnutrition-induced hepatic metabolic dysfunction with
non-alcoholic fatty liver disease
Severe malnutrition as well as overfeeding and obesity can cause
hepatic steatosis and mitochondrial changes, which in the con-
text of obesity is known as non-alcoholic fatty liver disease
(NAFLD). Enlarged mitochondria with abnormal cristae and
intracrystalline structures have been observed in NAFLD; in our
model we found mitochondrial inclusion bodies [43]. NAFLD
has been found to be associated with increased mitochondrial
mass [13,44], although liver mtDNA was decreased in a study
using livers from NAFLD patients [45]. Reduced complex I activity
has been found in NAFLD [46], although not consistently [re-
viewed in [9]]. Of note, choline deficient diet-induced steatosis
also causes reduced complex I activity [47]. Since impaired com-
plex I activity is found both in NAFLD and in our LPD model, one
might speculate that hepatic lipid accumulation is the cause
rather than the effect of the reduced complex I activity. However,
our finding that complex I activity is not restored by fenofibrate
treatment, while hepatic lipid content is reduced, suggests that
the impairment of complex I is a direct result of LPD. Some
changes in our model are not typically found in NAFLD. For exam-
ple, despite mitochondrial damage, a higher lipid oxidation rate
has been observed in NAFLD patients [See review [9]], which
was found to be reduced in our model. There is very limited data
on the role of peroxisomes in NAFLD. A few studies suggested an
increased peroxisome content in NAFLD [46,48], indicating that
the loss of peroxisomes is specific for malnutrition-related
steatosis. Detailed metabolic analyses in NAFLD does indicate
certain similarities with our model, including the effects on the
TCA cycle [49,50]. The effect of fenofibrate in increasing the
long-chain acylcarnitines in our model is intriguing. It has been
demonstrated that at least for muscle, obesity-induced mito-
chondria overload causes accumulation of intermediates that
subsequently induces insulin resistance and not so much a total
defect in oxidation as is often claimed [51]. Fibrates have been
proposed in the treatment of NAFLD but some authors found a
negative outcome [52]. As signs of incomplete oxidation are exac-
erbated by fenofibrate, long term treatment could be ineffective,
or even aggravate hepatic metabolic dysfunction, as was also pro-
posed [52].
Mechanisms for the malnutrition-induced loss of peroxisomes
In the present study peroxisomal structural and functional alter-
ations were not accompanied by decreased expression of perox-
isome biogenesis genes. Instead, the increase in autophagy
markers along with autophagy receptors involved in autophagic
degradation of peroxisomes suggests that the loss of peroxisomes
is likely due to an increase in pexophagy and not the reduction of
biogenesis. Amino acid deprivation is a potent inductor of pex-
ophagy [16]. The livers of starved mice have been reported to lose
over 40% of their protein content within 48 h [16]. Thus it is not
surprising that peroxisomes are selectively degraded during star-
vation as they are very protein-dense structures within a cell and
likely less critical for immediate survival of hepatocytes. Yet, the
induction of pexophagy during a prolonged period of starvation
may be detrimental, since peroxisomes prevent the accumulationvol. 65 j 1198–1208
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of bile acid intermediates that can be toxic to the liver [53].
Indeed, loss of peroxisomes observed in the present study was
accompanied by increased plasma levels of unconjugated C24
bile acids, possibly contributing to hepatic toxicity and damage.
The relation between peroxisomal and mitochondrial function
Although we could not directly demonstrate that the loss of per-
oxisomes resulted in impairedmitochondria function, there is evi-
dence to support this hypothesis. The importance of peroxisomes
for mitochondria fitness was initially described in the first report
of peroxisome biogenesis disorder where individuals lacking
detectable peroxisomes showed clear signs of dysfunctional and
deformed mitochondria [54]. Interestingly, animal models with
genetic deficiencies in peroxisomal biogenesis showed mitochon-
drial disturbances that were similar to those observed in our mal-
nutrition model such as lower complex I activity [12,55]. There is
some evidence showing that the loss of peroxisomal redox regu-
lation may negatively affect the redox status of mitochondria,
resulting in an increase in mitochondria oxidative stress [56].
Furthermore, the loss of peroxisomal VLCFA b-oxidation activity
results in the impairment of mitochondrial OXPHOS and mito-
chondria damage [57,58], albeit the underlying mechanism is
unknown. In analogue to the peroxisomal defect disease models,
we observed in our malnutrition model decreased numbers of
peroxisomes (Fig. 3A), an increase in oxidative stress (Fig. 1D),
the accumulation of VLCFA (Fig. 3C) and a decrease in OXPHOS
capacity (Fig. 5C). Together these results suggest that the loss of
peroxisomes and mitochondrial dysfunction during prolonged
malnutrition may be responsible for some of hepatic metabolic
defects observed in our animal model. This notion is further sup-
ported by the fact that treatment with PPARa agonist fenofibrate
resulted in a concerted reappearance of peroxisomes and normal-
ization of mitochondrial morphology and function, leading to
amelioration of hepatic phenotype.
Conclusions
This study is unique in its comprehensive approach to under-
stand the complex hepatic metabolic consequences of severe
malnutrition. It is the first study to demonstrate a diet-induced
loss of peroxisomes in vivo. The results of this study could poten-
tially lead to novel treatment strategies for severely malnour-
ished children. For example, numerous studies have shown that
hypoalbuminemia is strongly associated with increased mortality
in critically sick patients [59]. Interventions aimed at restoring
hepatic mitochondrial function and thereby raising serum albu-
min levels could lead to improved clinical outcome of severely
malnourished children. Since polyunsaturated FA, such as linoleic
and docosahexaenoic acid are strong natural ligands of PPARa
[60], it would be interesting to evaluate whether dietary supple-
mentation with these FA in the early phases of treatment would
improve hepatic function and clinical outcome of severely mal-
nourished children.Financial support
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